CompletedNot Applicable

Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma

Brazil50 participantsStarted 2008-09

Plain-language summary

The purpose of this study is to determine predictive factors in the pelvic magnetic resonance in the response of arterial embolization of uterine leiomyoma.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ultrasound diagnosis of uterine leiomyoma * presence of symptoms (menorrhalgia and/or pelvic pain) * indication for UAE(the desire to keep the uterus and/or contraindications for surgery). Exclusion Criteria: * malignant genital neoplasms * pelvic inflammatory disease * allergy to iodinated contrast * coagulopathy, renal failure * vasculitis * pelvic irradiation * pregnancy * subserosal leiomyoma with a pedicle smaller than 50% of diameter of the fibroid.

What they're measuring

Leiomyoma reduction in patients who underwent uterine artery embolization

Timeframe: One month before(baseline) and six month after the embolization

Trial details

NCT IDNCT01468402

SponsorHospital Israelita Albert Einstein

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2009-04

View on ClinicalTrials.gov More Exposure to Magnetic Field trials